Crysvita 10 mg/1 ml, Injektionslösung
7680668010011
CH-66801
Injektionslösung
Associated product:
CRYSVITA 10 mg/1 ml sol inj 10 mg 1 pce
1 / 2
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
burosumabum
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
sorbitolum
|
45.91 MG | Substance | HBESI |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Kyowa Kirin Sàrl
1201 Genève
Authorization information
- Swissmedic authorization number
- 66801
- Drug name
- Crysvita, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- M05BX05
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 20/01/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- CRYSVITA 10 mg/1 ml sol inj 10 mg 1 pce
- Description (DE)
- CRYSVITA 10 mg/1 ml Inj Lös 10 mg 1 Stk
- Market launch
- 20/01/2020
- Narcotic (BTM)
- No